{"id":36112,"date":"2024-06-05T12:28:30","date_gmt":"2024-06-05T10:28:30","guid":{"rendered":"https:\/\/petsvetcheck.de\/krankheiten-und-stoerungen\/hund\/adenokarzinom-der-haut-tumor-aus-druesengewebe-der-haut\/"},"modified":"2026-08-24T09:33:06","modified_gmt":"2026-08-24T07:33:06","slug":"cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin","status":"publish","type":"krankheit","link":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/","title":{"rendered":"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin)"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","krankheitsort":[138],"haufigkeit":[136],"organsystem_krankheiten":[208,234],"class_list":["post-36112","krankheit","type-krankheit","status-publish","hentry","krankheitsort-haut-fell-en","haufigkeit-b-en","organsystem_krankheiten-skin","organsystem_krankheiten-tumors","entry"],"acf":{"synonyme":"","synonyme_en":"Skin adenocarcinoma","titel_en":"Cutaneous adenocarcinoma","weitere_suchbegriffe":"Skin adenocarcinoma","triage":"yellow","triage_begruendung":"Can grow into tissue; prompt examination and removal advisable.","definition":"Adenocarcinoma of the skin (cutaneous adenocarcinoma) is a malignant tumor that arises from the glandular structures of the skin. These malignant neoplasias can originate from various gland types, including sebaceous, sweat, or apocrine glands. Unlike benign adenomas, adenocarcinomas show an invasive growth pattern and the potential for metastasis. Histologically, these tumors are characterized by atypical glandular cells that disrupt the normal tissue architecture and can infiltrate the surrounding tissue.   \n\n\u00a0","ursachen":"Cutaneous adenocarcinomas account for approximately 2\u20136% of all cutaneous neoplasias in dogs, making them among the rarer skin tumors. They occur predominantly in older dogs, with the average age of onset around 10\u201312 years. Certain breeds such as Cocker Spaniels, Poodles, and Labrador Retrievers appear to have a certain predisposition, suggesting genetic factors. The biological significance of these tumors lies in their locally aggressive behavior and their ability to metastasize to lymph nodes and distant organs, making them a serious oncological condition.   \n\nThe etiology of cutaneous adenocarcinomas is multifactorial and not fully understood. Scientific evidence suggests an interplay of various factors: \n\nGenetic predispositions play an important role, as evidenced by the increased occurrence in certain dog breeds. Molecular genetic studies have identified specific genetic alterations, including mutations in tumor suppressor genes and oncogenes, which can contribute to the malignant transformation of glandular cells. \n\nEnvironmental factors such as chronic UV exposure can contribute to carcinogenesis, particularly in thinly haired or unpigmented skin areas. Long-term exposure to chemical carcinogens in the environment is also considered a possible risk factor. \n\nA particularly important pathogenetic mechanism is the link between chronic inflammatory processes and tumor development. Persistent Skin inflammation can impair DNA repair mechanisms through continuous tissue damage, oxidative stress, and the release of inflammatory mediators, and promote malignant transformation. This explains why non-healing Skin inflammation can pose an increased risk for the development of adenocarcinomas.  \n\nHormonal factors are also discussed as possible influencing factors, particularly in tumors arising from hormone-dependent glandular structures. However, the evidence for this in cutaneous adenocarcinoma is less clear than in other tumor types. ","auswahl_symptome_rot":[34059,33424,33900,33602,33516],"auswahl_symptome_blau":[33774,33367,33548,33832,33186,33531],"auswahl_symptome_grun":[33793,34231,33810],"erganzungen_zu_symptomen":"The clinical presentation of cutaneous adenocarcinomas can vary, but shows characteristic features that are recognizable to the pet owner. Typically, these tumors present as solitary, firm Lumps in the skin or in the subcutaneous tissue. Size can range from a few millimeters to several centimeters, with larger tumors often having an irregular surface.  \n\nA significant clinical feature is the growth behavior: adenocarcinomas often show progressive growth over weeks to months. In advanced stages, the tumors can ulcerate, which can lead to Bleeding, secretions, and secondary bacterial infections. These complications manifest as weeping, an unpleasant odor, and pain at the affected site.  \n\nAffected dogs often show increased Licking or Scratching at the tumor site, indicating local Itching or discomfort. With tumors in mechanically stressed areas such as the paws or in joint regions, Lameness or Limited mobility can occur. \n\nIn advanced disease with metastasis, systemic symptoms may occur, including lethargy, inappetence, and Weight loss, and, depending on the location of the metastases, organ-specific symptoms. Enlarged regional lymph nodes may indicate lymphogenous metastasis and should therefore always be carefully palpated. \n\nParticularly problematic are adenocarcinomas that develop from chronic, non-healing inflammatory foci. Here, the transition from chronic dermatitis to a malignant process can be difficult for the owner to recognize, which underscores the importance of regular veterinary examinations for persistent skin changes. ","zusammenfassung":"Cutaneous adenocarcinoma in dogs is a malignant tumor that arises from the glandular structures of the skin and accounts for about 2\u20136% of all cutaneous neoplasias. These tumors occur predominantly in older dogs and are associated with a certain breed predisposition. The etiology is multifactorial, with genetic factors, environmental influences, and chronic inflammatory processes playing a role.  \n\nClinically, adenocarcinomas present as progressively growing, firm nodules that can ulcerate in advanced stages. Diagnosis is made through a combination of clinical examination, cytological and histopathological examination, and imaging procedures for staging. \n\nThe therapy of choice is wide surgical excision with tumor-free resection margins. In cases of incomplete resection or high-grade malignant tumors, adjuvant therapies such as radiation therapy or, in selected cases, chemotherapy may be indicated. Newer therapy approaches such as electrochemotherapy, targeted therapies, and immunotherapeutic procedures expand the therapeutic spectrum.  \n\nThe prognosis depends significantly on the tumor stage, histological grade, and completeness of surgical resection. Structured follow-up care with regular clinical examinations and imaging studies is essential to detect recurrence or metastases early. \n\nThe early detection of Skin changes by the owner and prompt veterinary clarification are crucial for an optimal treatment outcome. Owners should therefore be instructed to perform regular skin examinations on their dog and have changes clarified by a veterinarian immediately. \n\n\u00a0","diagnose":"<ul>\n \t<li>Biopsy of the lesion for histopathological examination.<\/li>\n \t<li>Imaging procedures such as ultrasound, X-ray, or CT to assess spread.<\/li>\n<\/ul>\nThe diagnosis of cutaneous adenocarcinoma requires a systematic approach that combines clinical, cytological, histopathological, and imaging procedures. The diagnostic algorithm begins with a thorough clinical examination, in which the size, consistency, mobility, and demarcation of the tumor as well as the condition of the regional lymph nodes are assessed. \n\nCytological examination via fine-needle aspiration is an important first diagnostic step. Cells are taken from the tumor and examined microscopically. Characteristic cytological findings in adenocarcinomas are cell clusters with clear signs of cellular atypia, anisocytosis, anisokaryosis, and prominent nucleoli. Cytology can provide valuable clues, but is not always sufficient for a definitive diagnosis.   \n\nThe gold standard for diagnosis is the histopathological examination of a biopsy. This can be performed as an incisional biopsy (removal of a piece of tissue) or as an excisional biopsy (complete removal of the tumor). Histopathological examination not only enables the definitive diagnosis of an adenocarcinoma, but also the determination of the histological subtype, degree of differentiation, and invasiveness, which is crucial for prognosis and therapy planning.  \n\nModern diagnostic procedures also include immunohistochemical examinations, which can confirm the epithelial origin of the tumor using specific markers such as cytokeratins. In certain subtypes, specific markers such as estrogen or progesterone receptors can provide additional prognostic information. \n\nImaging procedures are essential for assessing tumor stage and ruling out metastases. These include: \n<ul>\n \t<li>Chest X-rays in three views to rule out pulmonary metastases<\/li>\n \t<li>Abdominal ultrasound to assess abdominal organs and lymph nodes<\/li>\n \t<li>In complex cases, advanced imaging procedures such as computed tomography (CT) or magnetic resonance imaging (MRI) can be used to more precisely assess local tumor extent and detect smaller metastases<\/li>\n<\/ul>\nNewer diagnostic approaches such as liquid biopsy, in which circulating tumor DNA is detected in the blood, are still at the research stage in veterinary oncology, but could contribute in the future to early detection of recurrence \/ relapse or to monitoring therapy.","behandlung":"Surgical removal of the tumor with a healthy tissue margin.\nRadiation therapy or chemotherapy if surgical removal is not possible or in metastatic disease.\nFollow-up care for early detection of recurrence \/ relapse or metastases.\n\nThe therapy of cutaneous adenocarcinoma in dogs is based on a multimodal approach, with <a title=\"Surgery in Dogs or Cats: Procedure, Risks and Aftercare\" href=\"https:\/\/petsvetcheck.de\/ratgeber\/operation-bei-hund-oder-katze-ablauf-risiken-und-nachsorge\/\" data-wpil-monitor-id=\"338\">surgical<\/a> intervention remaining the most important treatment option. The choice of optimal therapeutic strategy depends on the tumor stage, location, histological grade, and the patient's general condition. \n\nSurgical excision with wide safety margins (at least 2\u20133 cm lateral as well as one fascial layer in depth) is the therapy of first choice. The goal is complete removal of the tumor with tumor-free resection margins (R0 resection), as this offers the best prognosis. In unfavorable locations or with large tumors, reconstructive surgical procedures such as local flap plasties or free skin grafts may be required to close the defect.  \n\nIn cases of incomplete resection (R1 or R2 resection) or high-grade malignant tumors, adjuvant radiation therapy is often recommended. Modern irradiation techniques such as intensity-modulated radiation therapy (IMRT) or stereotactic radiosurgery allow precise application of the radiation dose while sparing the surrounding healthy tissue. Radiation therapy can also be considered as a primary treatment option for inoperable tumors.  \n\nChemotherapy plays a subordinate role in the treatment of cutaneous adenocarcinoma but can be used in metastatic disease or as adjuvant therapy after incomplete resection. Commonly used chemotherapeutic agents include doxorubicin, carboplatin, and cyclophosphamide. However, response rates are variable and often not long-lasting.  \n\nNewer therapeutic approaches include:\n\nElectrochemotherapy, in which electrical impulses increase cell membrane permeability, leads to improved intracellular uptake of chemotherapeutic agents. This method has proven effective particularly for superficial tumors. \n\nTargeted therapies that focus on specific molecular changes in tumor cells are gaining increasing importance. Tyrosine kinase inhibitors such as toceranib have shown promising results in some cases. \n\nImmunotherapeutic approaches, including checkpoint inhibitors that activate the body\u2019s own immune system to fight tumor cells, are currently being investigated in clinical trials and could expand the therapeutic arsenal in the future.\n\nWhen deciding on therapy, the animal\u2019s age, comorbidities, the expected quality of life, and the owner\u2019s financial means must always be taken into account. An open discussion between veterinarian and owner about therapy options, chances of success, and possible side effects is appropriate for well-informed decision-making. ","prognose":"The prognosis for dogs with cutaneous adenocarcinoma is variable and depends on several factors. The most important prognostic factors include the histological grade of the tumor, the tumor stage at the time of diagnosis, the completeness of surgical resection, and the presence of metastases. \n\nWith complete surgical removal (R0 resection) of a low- to moderately malignant adenocarcinoma without metastases, the prognosis is comparatively favorable, with median survival times of 12 to 24 months. High-grade malignant tumors, incomplete resections, or the presence of metastases are associated with a significantly poorer prognosis, with median survival time dropping to 6\u201312 months or less. \n\nMolecular markers such as the expression of certain growth factor receptors or the proliferation rate (Ki-67 index) can provide additional prognostic information and are increasingly being incorporated into prognosis assessment.\n\nFollow-up care after treatment of adenocarcinoma is an essential component of the overall management and includes several components:\n\nRegular clinical examinations are particularly important in the first two years after therapy, as the risk of local recurrence and metastases is highest during this period. Monthly examinations are recommended in the first six months, after which the intervals can be extended to three to four months. \n\nFollow-up examinations should include a thorough clinical examination, with particular attention to the surgical site and the regional lymph nodes. Diagnostic imaging such as X-ray of the thorax \/ chest and ultrasound of the abdomen are performed at regular intervals (every 3\u20136 months) to detect metastases early. \n\nIn dogs receiving chemotherapy or targeted therapy, regular blood tests are required to monitor possible side effects and adjust the dose.\n\nWound care after surgical procedures is an important aspect of follow-up care. Owners should be instructed on how to recognize signs of wound-healing disorders or infections and when to seek veterinary help. \n\nSupportive measures to improve quality of life, such as adequate pain therapy \/ analgesic therapy, an adapted diet, and, if necessary, physiotherapeutic measures, should be integrated into the follow-up concept.","ausblick_auf_aktuelle_forschung":"Research in the field of canine cutaneous adenocarcinomas is continuously evolving and opening up new perspectives for diagnosis and therapy. Current research focuses include molecular characterization, innovative therapy approaches, and improved prognostic markers. \n\nIn molecular oncology, genetic and epigenetic alterations in cutaneous adenocarcinomas are increasingly being identified. Using techniques such as next-generation sequencing and proteomics, specific mutations and altered signaling pathways can be characterized that represent potential targets for targeted therapies. Identifying driver mutations, similar to human adenocarcinoma, could enable the development of personalized therapy strategies.  \n\nA promising area of research is immuno-oncology. Investigating the tumor microenvironment and the interaction between tumor cells and the immune system has led to the development of new immunotherapeutic approaches. Checkpoint inhibitors, which are already established in human medicine, are increasingly being evaluated in veterinary studies. Initial results show promising response rates in certain tumor entities, although efficacy in cutaneous adenocarcinomas still needs further investigation.   \n\nThe development of minimally invasive therapy procedures is another research focus. Techniques such as photodynamic therapy, in which light-activated substances selectively destroy tumor cells, or high-frequency thermoablation are being investigated for their applicability in superficial skin tumors. \n\nIn diagnostics, advances in diagnostic imaging, such as high-resolution ultrasound procedures, functional MRI techniques, or PET-CT, enable more precise tumor characterization and staging. Liquid biopsy, in which circulating tumor DNA or tumor cells are detected in the blood, could in the future represent a minimally invasive method for tumor diagnosis, therapy monitoring, and detection of recurrence \/ relapse. \n\nTranslational research approaches that transfer findings from human medicine to veterinary medicine are gaining increasing importance. Comparative oncology studies that examine similarities and differences between human and canine tumors can contribute to a better understanding of tumor biology and the development of new therapeutic approaches. \n\nThe integration of artificial intelligence and machine learning into oncological diagnostics and therapy planning represents an innovative research approach. Algorithms for automated analysis of histopathological images or for predicting therapy response could support clinical decision-making in the future. ","zusatzlicher_inhalt_im_hauptteil":"For prevention of cutaneous adenocarcinoma, early detection is crucial. Regularly palpating the dog, especially in older animals, allows suspicious lumps to be detected early. Wounds or Skin changes that do not heal within two weeks should be examined by a veterinarian. Excessive sun exposure, especially in dogs with light skin or thin coat, should be avoided. A balanced diet and an intact immune system contribute to skin health. Since genetic factors may play a role, careful breeding selection is important. The earlier a skin tumor is detected, the higher the chances of successful treatment.      ","haufig_gestellte_fragen_faqs":"<ol>\n \t<li><strong>What is a cutaneous adenocarcinoma in dogs?<\/strong><\/li>\n<\/ol>\nA cutaneous adenocarcinoma is a malignant tumor that arises from glandular skin cells. These cells may be sebaceous or sweat glands and often grow invasively into the surrounding tissue. According to standard references (e.g., <i>\u201cVeterinary Oncology\u201d<\/i> by Withrow & Vail), they are rarer than other skin tumors, but still significant.\n\n<strong>2. What symptoms indicate a cutaneous adenocarcinoma?<\/strong>\n\nTypical symptoms are nodular, hardened skin changes that are often irregular or ulcerated. There may be redness, hair loss, oozing areas, or itching. Rapid growth of the lump is also a warning sign. According to <a href=\"https:\/\/petsvetcheck.de\">petsvetcheck.de<\/a>, all newly occurring or growing lumps should be medically clarified.   \n\n<strong>3. How is the diagnosis made?<\/strong>\n<ul>\n \t<li>Clinical examination: Visual inspection and palpation of the skin.<\/li>\n \t<li>Fine-needle aspiration or biopsy: collection of tissue samples for cytological or histopathological examination.<\/li>\n \t<li>Imaging: X-ray, ultrasound, CT, or MRI can assess the extent of spread.<\/li>\n<\/ul>\nStandard veterinary references (e.g., <em>Slatter\u2019s Fundamentals of Veterinary Ophthalmology<\/em>\u2014although the focus here is more on the eye, it contains chapters on skin tumors in relation to periocular structures) recommend detailed histology for prognosis assessment.\n\n<strong>4. What Treatment Options are Available?<\/strong>\n<ul>\n \t<li>Surgical removal: often the therapy of choice, if possible, with wide safety margins to avoid recurrence \/ relapse.<\/li>\n \t<li>Radiation therapy: as an adjunct in cases of incomplete resection or if the tumor is located in a critical area.<\/li>\n \t<li>Chemotherapy or immunotherapy: in special cases, such as metastasis or inoperable tumors.<\/li>\n \t<li>Electrochemotherapy: Combines chemotherapeutic agents with electrical impulses to increase drug uptake into cancer cells.<\/li>\n<\/ul>\nCurrent studies indicate that molecular approaches will gain importance in the future (cf. <em>Veterinary Ophthalmology<\/em>, Gelatt et al.\u2014also contains general tumor biology). \n\n<strong>5. What is the prognosis for cutaneous adenocarcinomas?<\/strong>\n\nPrognosis varies greatly depending on location, tumor size, grade of malignancy, and metastatic behavior. If the tumor is detected early and completely removed, the chances of cure are significantly better. In advanced stages or with metastases, the prognosis may be guarded. According to the <em>BSAVA Manual of Small Animal Oncology<\/em>, thorough diagnostics are crucial for prognosis.   \n\n<strong>6. Can cutaneous adenocarcinomas metastasize in dogs?<\/strong>\n\nYes, adenocarcinomas can affect lymph nodes as well as organs such as the lungs, liver, or spleen. Therefore, lymph node examination and diagnostic imaging screening (X-ray, CT) are important. According to <a href=\"https:\/\/petsvetcheck.de\">petsvetcheck.de<\/a>, metastases are sought early, especially with larger tumor volume or a high grade of malignancy.  \n\n<strong>7. What role does the breed play?<\/strong>\n\nSome breeds are generally prone to skin tumors (e.g., Boxers, Labradors, Golden Retrievers), although cutaneous adenocarcinoma is not as common as mast cell tumors or melanomas. A genetic connection in glandular tumors is discussed but is less clearly established. In professional circles (cf. <em>Veterinary Oncology<\/em>, Withrow & Vail), relatively few breed-specific data are found for adenocarcinomas compared to mast cell tumors or hemangiosarcomas.  \n\n<strong>8. How can I prevent cutaneous adenocarcinomas?<\/strong>\n\nDirect prevention is difficult because the exact causes can vary (e.g., genetic predisposition, environmental influences). Nevertheless, the following help: \n<ul>\n \t<li>Regular check: Palpate the dog's fur and skin to detect changes early.<\/li>\n \t<li>Healthy diet and weight control: A strong immune system can curb tumor growth.<\/li>\n \t<li>Sun protection: In dogs with thin or light-colored coats, excessive UV exposure can increase the risk of skin cancer.<\/li>\n<\/ul>\n<strong>9. What does aftercare look like?<\/strong>\n<ul>\n \t<li>Wound control: After an <a title=\"Surgery in Dogs or Cats: Procedure, Risks and Aftercare\" href=\"https:\/\/petsvetcheck.de\/?page_id=31154\" data-wpil-monitor-id=\"243\">operation<\/a>, check the surgical site regularly.<\/li>\n \t<li>Follow-up examinations: After surgical removal of a malignant tumor, routine appointments with the veterinarian are recommended (e.g., every 3\u20136 months).<\/li>\n \t<li>Possible imaging procedures: Chest X-ray, abdominal ultrasound to rule out metastases.<\/li>\n<\/ul>\n<strong>10. Can a dog continue to live normally after removal of a cutaneous adenocarcinoma?<\/strong>\n\nYes, with complete removal and no metastases, quality of life is often excellent. Many dogs recover well from the <a title=\"Surgery in Dogs or Cats: Procedure, Risks and Aftercare\" href=\"https:\/\/petsvetcheck.de\/ratgeber\/operation-bei-hund-oder-katze-ablauf-risiken-und-nachsorge\/\" data-wpil-monitor-id=\"287\">surgery<\/a> and live symptom-free. However, with more aggressive tumor forms or recurrences \/ relapses, it may be necessary to consider further therapies (e.g., radiation therapy, chemotherapy).  ","literaturangaben":"<ul>\n \t<li>Goldschmidt, M. H., & Goldschmidt, K. H. (2017). Epithelial and melanocytic tumors of the skin. In D. J. Meuten (Ed.), Tumors in domestic animals (5th ed., pp. 88\u2013141). Wiley Blackwell.    https:\/\/doi.org\/10.1002\/9781119181200.ch4<\/li>\n \t<li>Martins, A. L., Canadas-Sousa, A., Mesquita, J. R., Dias-Pereira, P., Amorim, I., & G\u00e4rtner, F. (2022). Retrospective study of canine cutaneous tumors submitted to a diagnostic pathology laboratory in Northern Portugal (2014\u20132020). Canine Medicine and Genetics, 9, Article 2. https:\/\/doi.org\/10.1186\/s40575-022-00113-w  <\/li>\n \t<li>Tangchang, W., Jung, G.-y., Song, J.-y., Kumbukgahadeniya, P., Kim, D.-h., Kwon, H.-j., & Son, H.-y. (2024). Endocrine mucin-producing sweat gland carcinoma (EMPSGC) in a dog: Immunohistochemical characterization. Animals, 14(24), 3637. https:\/\/doi.org\/10.3390\/ani14243637<\/li>\n \t<li>Moon, C.-H., Min, H.-A., Lee, H.-B., Jeong, S.-M., & Kim, D.-H. (2022). Retroperitoneal metastatic apocrine gland ductal adenocarcinoma in a Beagle dog. Veterinary Sciences, 9(5), 234. https:\/\/doi.org\/10.3390\/vetsci9050234<\/li>\n \t<li>Akhtardanesh, B., Kheirandish, R., Dabiri, S., Azari, O., Vosoogh, D., & Askari, N. (2012). Metastatic apocrine sweat gland adenocarcinoma in a terrier dog. Asian Pacific Journal of Tropical Biomedicine, 2(8), 670\u2013672.   https:\/\/doi.org\/10.1016\/S2221-1691(12)60118-X<\/li>\n \t<li>Kato, K., Uchida, K., Nibe, K., & Tateyama, S. (2007). Immunohistochemical studies on cytokeratin 8 and 18 expressions in canine cutaneous adnexus and their tumors. Journal of Veterinary Medical Science, 69(3), 233\u2013239.   https:\/\/doi.org\/10.1292\/jvms.69.233<\/li>\n \t<li>Schulman, F. Y., Lipscomb, T. P., & Atkin, T. J. (2005). Canine cutaneous clear cell adnexal carcinoma: Histopathology, immunohistochemistry, and biologic behavior of 26 cases. Journal of Veterinary Diagnostic Investigation, 17(5), 403\u2013411.   https:\/\/doi.org\/10.1177\/104063870501700501<\/li>\n \t<li>Simko, E., Wilcock, B. P., & Yager, J. A. (2003). A retrospective study of 44 canine apocrine sweat gland adenocarcinomas. The Canadian Veterinary Journal, 44(1), 38\u201342.  <\/li>\n \t<li>Kalaher, K. M., Anderson, W. I., & Scott, D. W. (1990). Neoplasms of the apocrine sweat glands in 44 dogs and 10 cats. Veterinary Record, 127(16), 400\u2013403.  <\/li>\n<\/ul>","symptome_ausgeblendet":"","erganzungen":"","faq":[{"frage":"1. What is a cutaneous adenocarcinoma in dogs?","antwort":"A skin adenocarcinoma is a malignant tumor that arises from glandular skin cells. These cells may be sebaceous or sweat glands and often grow invasively into surrounding tissue. According to standard references (e.g., Withrow & Vail\u2019s Veterinary Oncology), they are less common than other skin tumors but clinically significant.  "},{"frage":"2. What symptoms indicate a cutaneous adenocarcinoma?","antwort":"Typical symptoms include nodular, firm Skin changes that are often irregular or ulcerated (open sores). Redness, hair loss, oozing areas, or Itching may occur. Rapid growth of the lump is also a warning sign. According to petsvetcheck.de, any newly appearing or growing lumps should be checked by a veterinarian.   "},{"frage":"3. How is the diagnosis made?","antwort":"- Clinical examination: visual inspection and palpation of the skin. - Fine-needle aspiration or biopsy: collection of tissue samples for cytological or histopathological examination. - Imaging: X-ray, ultrasound, CT, or MRI can assess the extent of spread. Standard veterinary references (e.g., Slatter\u2019s Fundamentals of Veterinary Ophthalmology\u2014although the focus here is more on the eye, it contains chapters on skin tumors in relation to periocular structures) recommend detailed histology to assess prognosis.   "},{"frage":"4. What Treatment Options are Available?","antwort":"- Surgical removal: often the therapy of choice, if possible, with wide safety margins to prevent recurrence. - Radiation therapy: as an addition after incomplete resection or if the tumor is in a critical location. - Chemotherapy or immunotherapy: in special cases, such as metastasis or inoperable Tumors. - Electrochemotherapy: combines chemotherapy drugs with electrical pulses to increase uptake of the active ingredient into cancer cells. Current studies indicate that molecular approaches will become more important in the future (see Veterinary Ophthalmology, Gelatt et al.\u2014also includes general tumor biology).    "},{"frage":"5. What is the prognosis for cutaneous adenocarcinomas?","antwort":"The prognosis varies widely depending on location, tumor size, degree of malignancy, and metastatic behavior. If the tumor is detected early and completely removed, the chances of cure are significantly better. In advanced stages or with metastases, the prognosis may be guarded. According to the BSAVA Manual of Small Animal Oncology, thorough diagnostics are crucial for the prognosis.   "},{"frage":"6. Can cutaneous adenocarcinomas metastasize in dogs?","antwort":"Yes, adenocarcinomas can affect lymph nodes and organs such as the lungs, liver, or spleen. Therefore, examining the lymph nodes and imaging screening (X-ray, CT) are important. According to petsvetcheck.de, it is recommended to look for metastases early, especially with larger tumor volume or a high degree of malignancy.  "},{"frage":"7. What role does the breed play?","antwort":"Some breeds are generally prone to skin tumors (e.g., Boxers, Labradors, Golden Retrievers), although skin adenocarcinoma is not as common as mast cell tumors or melanomas. A genetic link in glandular tumors is discussed, but the evidence is less clear. In specialist circles (see Withrow & Vail, Veterinary Oncology), there is relatively little breed-specific data on adenocarcinomas compared with mast cell tumors or hemangiosarcomas.  "},{"frage":"8. How can I prevent cutaneous adenocarcinomas?","antwort":"Direct prevention is difficult because the exact causes can vary (genetic predisposition, environmental influences). Still, the following can help: - Regular checks: feel your dog\u2019s coat and skin to spot changes early. - Healthy diet and weight control: a strong immune system may potentially limit tumor growth. - Sun protection: in dogs with thin or light-colored coats, excessive UV exposure can increase the risk of skin cancer.   "},{"frage":"9. What does aftercare look like?","antwort":"- Wound checks: after surgery, check the surgical site regularly. - Follow-up exams: after surgical removal of a malignant tumor, routine appointments with your veterinarian are recommended (e.g., every 3\u20136 months). - Possible imaging: chest X-ray, abdominal ultrasound to rule out metastases.  "},{"frage":"10. Can a dog continue to live a normal life after the removal of a cutaneous adenocarcinoma?","antwort":"Yes, if it is completely removed and there are no metastases, quality of life is often excellent. Many dogs recover well from surgery and live symptom-free. However, with more aggressive tumor types or recurrences, it may be necessary to consider further therapies (e.g., radiation therapy, chemotherapy).  "}],"faq_html":null},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin) in dogs<\/title>\n<meta name=\"description\" content=\"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin)\" \/>\n<meta property=\"og:description\" content=\"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/\" \/>\n<meta property=\"og:site_name\" content=\"PETSVETCHECK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/petsvetcheck.de\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-24T07:33:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\\\/\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\\\/\",\"name\":\"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin) in dogs\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#website\"},\"datePublished\":\"2024-06-05T10:28:30+00:00\",\"dateModified\":\"2026-08-24T07:33:06+00:00\",\"description\":\"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\",\"name\":\"PETSVETCHECK\",\"description\":\"Gesundheit f\u00fcr Hund und Katze\",\"publisher\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#organization\",\"name\":\"PETSVETCHECK\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/wp-content\\\/uploads\\\/logo-petsvetcheck-dunkel.svg\",\"contentUrl\":\"https:\\\/\\\/petsvetcheck.de\\\/wp-content\\\/uploads\\\/logo-petsvetcheck-dunkel.svg\",\"width\":1246,\"height\":169,\"caption\":\"PETSVETCHECK\"},\"image\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/petsvetcheck.de\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin) in dogs","description":"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/","og_locale":"en_US","og_type":"article","og_title":"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin)","og_description":"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.","og_url":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/","og_site_name":"PETSVETCHECK","article_publisher":"https:\/\/www.facebook.com\/petsvetcheck.de\/","article_modified_time":"2026-08-24T07:33:06+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/","url":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/","name":"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin) in dogs","isPartOf":{"@id":"https:\/\/petsvetcheck.de\/en\/#website"},"datePublished":"2024-06-05T10:28:30+00:00","dateModified":"2026-08-24T07:33:06+00:00","description":"Adenocarcinoma of the skin in dogs. Our site provides valuable insights into diagnosis, treatment, and care for affected dogs.","breadcrumb":{"@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/cutaneous-adenocarcinoma-tumor-from-glandular-tissue-of-the-skin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/petsvetcheck.de\/en\/"},{"@type":"ListItem","position":2,"name":"Malignant tumor of the skin glands in dogs (Adenocarcinoma of the skin)"}]},{"@type":"WebSite","@id":"https:\/\/petsvetcheck.de\/en\/#website","url":"https:\/\/petsvetcheck.de\/en\/","name":"PETSVETCHECK","description":"Gesundheit f\u00fcr Hund und Katze","publisher":{"@id":"https:\/\/petsvetcheck.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/petsvetcheck.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/petsvetcheck.de\/en\/#organization","name":"PETSVETCHECK","url":"https:\/\/petsvetcheck.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/petsvetcheck.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/petsvetcheck.de\/wp-content\/uploads\/logo-petsvetcheck-dunkel.svg","contentUrl":"https:\/\/petsvetcheck.de\/wp-content\/uploads\/logo-petsvetcheck-dunkel.svg","width":1246,"height":169,"caption":"PETSVETCHECK"},"image":{"@id":"https:\/\/petsvetcheck.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/petsvetcheck.de\/"]}]}},"_links":{"self":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheit\/36112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheit"}],"about":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/types\/krankheit"}],"acf:post":[{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33810"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34231"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33793"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33531"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33186"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33832"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33548"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33367"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33774"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33516"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33602"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33900"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33424"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34059"}],"wp:attachment":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/media?parent=36112"}],"wp:term":[{"taxonomy":"krankheitsort","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheitsort?post=36112"},{"taxonomy":"haufigkeit","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/haufigkeit?post=36112"},{"taxonomy":"organsystem_krankheiten","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/organsystem_krankheiten?post=36112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}